Literature DB >> 7213507

Prediction of phenytoin dosage in relation to the variability of phenytoin plasma concentration.

E A Van der Velde, O Driessen.   

Abstract

1 In a model study the influence of some variables on the accuracy of predictions of phenytoin doses which should produce desired plasma concentrations were studied. All predictions were extrapolations from low test doses with concurrent observations of plasma concentrations. 2 The variables in introduced were:--Variability in observed plasma concentration;--Variability in applied test doses;--Variability in patient characteristics as expressed in Km and Vmax values. 3 The model study generated the same sort of result as a previous one, executed in practice (Driessen. Van der Velde + Höppener, 1980), i.e. predictions are often inaccurate and of the method tested (Richens & Dunlop, 1975; Ludden, Hawkins, Allen & Hoffman, 1976; Martin, Tozer, Sheiner & Riegelman, 1977; Rambeck, Boenigk, Dunlop, Mullen, Wadsworth & Richens, 1980), Richens' first nomogram (Richens & Dunlop, 1975) is to be preferred.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213507      PMCID: PMC1401700          DOI: 10.1111/j.1365-2125.1981.tb01100.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Diphenylhydantoin.

Authors:  A J Glazko
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

2.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

3.  Plasma levels of phenobarbital and phenytoin in epileptic outpatients.

Authors:  O Driessen; R Höppener
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

4.  Serum-phenytoin levels in management of epilepsy.

Authors:  A Richens; A Dunlop
Journal:  Lancet       Date:  1975-08-09       Impact factor: 79.321

5.  Optimal phenytoin therapy: a new technique for individualizing dosage.

Authors:  P W Mullen
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

6.  Errors in measuring drug concentrations.

Authors:  W McCormick; J A Ingelfinger; G Isakson; P Goldman
Journal:  N Engl J Med       Date:  1978-11-16       Impact factor: 91.245

7.  Practical and theoretical aspects of phenytoin administration. I. Relationship between dose and plasma concentration.

Authors:  O Driessen; R J Höppener; E A van der Velde
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

8.  Practical and theoretical aspects of phenytoin administration. II. Prediction of plasma concentration.

Authors:  O Driessen; E A van der Velde; R J Höppener
Journal:  Eur Neurol       Date:  1980       Impact factor: 1.710

9.  The clinical pharmacokinetics of phenytoin.

Authors:  E Martin; T N Tozer; L B Sheiner; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

10.  One drug (phenytoin) in the treatment of epilepsy.

Authors:  E H Reynolds; D Chadwick; A W Galbraith
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.